Swiss Spinal Tumor Registry (Swiss-STR)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLuzerner Kantonsspital
About this trial
The Swiss Spinal Tumor Registry is a prospective REDCap-based registry, collecting data of surgically treated patients with primary and metastatic tumors of the spine.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of primary spinal tumor
Diagnosis of secondary (metastatic) spinal tumor
Indication for surgical treatment is present
Patient age: =/>18 years
Disqualifiers
Withdrawal of consent
Withdrawal from initially planned surgical procedure
Patient age: <18 years
Trial population
Adult patients suffering from primary or metastatic spinal tumors, undergoing surgery
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
250 Participants
are grouped into 1 trial groupGroup A: Swiss-STR Cohort
Trial outcomes
Primary outcomes
1
Functional Outcome as assessed by Karnofsky Performance Status Scale
Rating in 10% steps * 100 Normal no complaints; no evidence of disease. * 90 Able to carry on normal activity; minor signs or symptoms of disease. * 80 Normal activity with effort; some signs or symptoms of disease. * 70 Cares for self; unable to carry on normal activity or to do active work. * 60 Requires occasional assistance, but is able to care for most of his personal needs. * 50 Requires considerable assistance and frequent medical care. * 40 Disabled; requires special care and assistance. * 30 Severely disabled; hospital admission is indicated although death is not imminent. * 20 Very sick; hospital admission necessary; active supportive treatment necessary. * 10 Moribund; fatal processes progressing rapidly. * 0 Dead
Time frame
Through study completion, an average of 1 year2
Physical performance assessed by the Timed-Up-and-Go-Test (TUG)
Timed-Up-and-Go-Test in seconds
Time frame
Through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov